The cervical cancer vaccine is available at age 30, but only for bivalent and quadrivalent vaccines, and the target groups for each vaccination are different. The bivalent vaccine is for ages 9-45, the quadrivalent vaccine is for ages 20-45, and the nine-valent vaccine is for ages 16-26. The bivalent and quadrivalent vaccines are also very effective. The bivalent is HPV16 and HPV18, which mainly prevents cervical cancer and reduces the incidence of cervical cancer by about 70 percent, and if the quadrivalent cervical cancer vaccine is used, it can prevent cervical cancer and at the same time prevent acromegaly, because there are also HPV6 and HPV11 viral infections that can be prevented.